Sector Alpha Week of 2026-09-17
Not SEBI Registered !! Not Investment advice !!
20-quarter listed-company comparison

Medical Equipment Stocks in India

Medical Equipment: Poly Medicure Ltd owns the largest revenue base AND the fastest current growth.

The 6 Medical Equipment companies listed in India are Poly Medicure Ltd (₹17.6K Cr, the largest), Tarsons Products Ltd, Laxmi Dental Ltd and 3 more. 3 of 6 covered companies beat NIFTY 500 on relative strength. Readings are as of 17 Sep 2026.

All 6 Medical Equipment Stocks in India (Sep 2026) — ranked by 4-Factor score

  1. 1Prevest Denpro Ltd₹510 Cr64.2/100Thin evidence · provisional · strongest on ROCE and relative strength versus sector
  2. 2Laxmi Dental Ltd₹1.1K Cr53.0/100Mixed-positive evidence · strongest on profit growth and ROCE improvement
  3. 3Poly Medicure Ltd₹17.6K Cr37.3/100Mixed-negative evidence · strongest on revenue growth and operating margin
  4. 4Vasa Denticity Ltd₹676 Cr32.8/100Adverse evidence · strongest on margin improvement and revenue growth
  5. 5Tarsons Products Ltd₹1.7K Cr28.0/100Adverse evidence · strongest on relative strength versus the benchmark and operating margin
  6. 6Hemant Surgical Industries Ltd₹681 Cr56.5/100Thin evidence · provisional · strongest on ROCE and relative strength versus the benchmark

Ranked by the 4-Factor Sector Score (growth & earnings 35, capital efficiency 25, valuation 20, relative strength 20). Prices as of 11 Sep 2026. Not investment advice.

01 · the index people search for

Nifty Medical Equipment Index — Constituents & Performance

All 6 listed Indian Medical Equipment companies are named here, largest first — the same constituent set people search for as the Nifty Medical Equipment index. Every figure is equal-weighted across those companies and carries its own as-of date. One large constituent cannot set the reading.

  1. Poly Medicure Ltd₹17.6K Cr
  2. Tarsons Products Ltd₹1.7K Cr
  3. Laxmi Dental Ltd₹1.1K Cr
  4. Hemant Surgical Industries Ltd₹681 Cr
  5. Vasa Denticity Ltd₹676 Cr
  6. Prevest Denpro Ltd₹510 Cr
02 · the sector itself · before any single company

How has Medical Equipment moved against NIFTY 500?

The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 0% ahead of NIFTY 500. Earnings across its companies fell 28% on average over the last four reported quarters.

TURNING · ahead 3w~Moving with the index4 of 6 companies ahead of NIFTY 500 by 5% or more over three months

RS ↑3w · 3/6 >200d (+0) · 4/6 lead (+2) · EPS 2/5↑

20020262025202420232022 423303 TRAILING 12-MONTH EPS · 100 AT THE START0100107Jun 24Dec 24Jun 25Dec 25Jun 26Jun 2024 · trailing 12-month earnings per share at 100, against 100 at the start · up 25.3% on a year ago · 3 reportingSep 2024 · trailing 12-month earnings per share at 102, against 100 at the start · up 12.8% on a year ago · 5 reportingDec 2024 · trailing 12-month earnings per share at 107, against 100 at the start · up 14.6% on a year ago · 5 reportingMar 2025 · trailing 12-month earnings per share at 105, against 100 at the start · up 19.2% on a year ago · 5 reportingJun 2025 · trailing 12-month earnings per share at 100, against 100 at the start · up 22.3% on a year ago · 5 reportingSep 2025 · trailing 12-month earnings per share at 97, against 100 at the start · down 14.9% on a year ago · 6 reportingDec 2025 · trailing 12-month earnings per share at 78, against 100 at the start · down 32.0% on a year ago · 5 reportingMar 2026 · trailing 12-month earnings per share at 60, against 100 at the start · down 44.6% on a year ago · 5 reportingJun 2026 · trailing 12-month earnings per share at 39, against 100 at the start · down 22.2% on a year ago · 4 reportingNot reported yet — earnings trail price by a quarter or two39No earnings on file this far back — the price series reaches further than the filings doNO EARNINGS ON FILE
20020262025202420232022 423303 TRAILING 12-MONTH EPS · 100 AT THE START0100107Jun 24Jun 25Jun 26Jun 2024 · trailing 12-month earnings per share at 100, against 100 at the start · up 25.3% on a year ago · 3 reportingSep 2024 · trailing 12-month earnings per share at 102, against 100 at the start · up 12.8% on a year ago · 5 reportingDec 2024 · trailing 12-month earnings per share at 107, against 100 at the start · up 14.6% on a year ago · 5 reportingMar 2025 · trailing 12-month earnings per share at 105, against 100 at the start · up 19.2% on a year ago · 5 reportingJun 2025 · trailing 12-month earnings per share at 100, against 100 at the start · up 22.3% on a year ago · 5 reportingSep 2025 · trailing 12-month earnings per share at 97, against 100 at the start · down 14.9% on a year ago · 6 reportingDec 2025 · trailing 12-month earnings per share at 78, against 100 at the start · down 32.0% on a year ago · 5 reportingMar 2026 · trailing 12-month earnings per share at 60, against 100 at the start · down 44.6% on a year ago · 5 reportingJun 2026 · trailing 12-month earnings per share at 39, against 100 at the start · down 22.2% on a year ago · 4 reportingNot reported yet — earnings trail price by a quarter or two39No earnings on file this far back — the price series reaches further than the filings doNO EARNINGS ON FILE
Medical Equipment, equal-weighted, based at 200 NIFTY 500, same base, same start trailing 12-month earnings per share rising falling

Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 6 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.

03 · sector relative strength, before individual stocks

Is Medical Equipment outperforming NIFTY 500?

Medical Equipment has underperformed NIFTY 500 by 4.3% over the last 52 weeks. Over 13 weeks the gap is a lead of 18.6%. 3 of 6 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Prevest Denpro Ltd is the strongest against the sector itself at +21.2%. Readings are as of 2026-08-22.

+18.6%Sector vs NIFTY 500 · 13 weeks
-4.3%Sector vs NIFTY 500 · 52 weeks
3/6Stocks leading NIFTY 500
1/5Stocks leading sector

Sector metric: 33.1 as of 2026-08-22 · BROADENING · falling.

The central tension: current leadership is concentrated, so durability matters more than rank.

Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.

Bottom line

Medical Equipment has underperformed NIFTY 500 by 4.3% over 52 weeks and 18.6% over 13 weeks. 3 of 6 covered companies beat NIFTY on Mansfield relative strength, while 1 of 5 beat the sector itself. Poly Medicure Ltd leads with revenue of ₹1,998 crore, based on 5 of 6 comparable companies through Jun 2026.

Companies
6
complete canonical membership
Combined market value
₹22.3K Cr
Poly Medicure Ltd
Revenue growing
5/5
positive TTM year-on-year growth
Beating NIFTY 500
3/6
positive Mansfield relative strength
Comparing 5 of 6
04 · research priority, made explicit

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%
Prevest Denpro Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 56.9% evidence confidence.
How this score is built, and what the marks mean

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Prevest Denpro LtdPREVEST 64.2/100Thin evidence · provisional57% evidence 18.9/35 Revenue 17.3% · PAT 17% · OPM change -0.6 pp 53% evidence 18.9/25 ROCE 25.2% · OPM 33.9% 57% evidence 13.8/20 P/E 24.8× · PEG — 50% evidence 12.6/20 RS sector 21.2% · RS bench -12.7% · 1Y -27.2%3 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 18.9 + 18.9 + 13.8 + 12.6 = 64.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2Laxmi Dental LtdLAXMIDENTL 53.0/100Mixed-positive evidence74% evidence ASLEEP 25.7/35 Revenue 16.7% · PAT 34.8% · OPM change 1 pp 95% evidence 12.1/25 ROCE 14.9% · OPM 19% 95% evidence 10.9/20 P/E 32.1× · PEG — 15% evidence 4.3/20 RS sector -18.5% · RS bench -12.4% · 1Y -38.9%4 of 11 weeks ahead 70% evidence
Exact sum: 25.7 + 12.1 + 10.9 + 4.3 = 53 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -18.5% and the one-year return is -38.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
3Poly Medicure LtdPOLYMED 37.3/100Mixed-negative evidence100% evidence BREAKING OUT 14.3/35 Revenue 18.4% · PAT -12.3% · OPM change -2 pp 100% evidence 10.9/25 ROCE 12.5% · OPM 24% 100% evidence 4.1/20 P/E 55.1× · PEG 3.87 100% evidence 8.0/20 RS sector -5.7% · RS bench 7.4% · 1Y -14.9%10 of 12 weeks ahead 100% evidence
Exact sum: 14.3 + 10.9 + 4.1 + 8 = 37.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Vasa Denticity LtdDENTALKART 32.8/100Adverse evidence81% evidence TURNING 15.4/35 Revenue 17.9% · PAT -30.2% · OPM change 1.1 pp 95% evidence 5.2/25 ROCE 8.6% · OPM 6.1% 95% evidence 7.7/20 P/E 58.3× · PEG — 50% evidence 4.5/20 RS sector -6% · RS bench -18.1% · 1Y -36.4%3 of 10 weeks ahead 70% evidence
Exact sum: 15.4 + 5.2 + 7.7 + 4.5 = 32.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Tarsons Products LtdTARSONS 28.0/100Adverse evidence81% evidence BREAKING OUT 5.9/35 Revenue 10.6% · PAT -59.7% · OPM change -3.5 pp 95% evidence 4.6/25 ROCE 4.6% · OPM 23.6% 95% evidence 5.4/20 P/E 140× · PEG — 50% evidence 12.1/20 RS sector -3.9% · RS bench 27.5% · 1Y -2.6%10 of 10 weeks ahead 70% evidence
Exact sum: 5.9 + 4.6 + 5.4 + 12.1 = 28 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Hemant Surgical Industries Ltd543916 56.5/100Thin evidence · provisional31% evidence TURNING 17.8/35 Revenue — · PAT — · OPM change 0 pp 10% evidence 15.9/25 ROCE 19.6% · OPM 9% 76% evidence 10.3/20 P/E 37.4× · PEG — 15% evidence 12.5/20 RS sector — · RS bench 47.3% · 1Y —8 of 12 weeks ahead 25% evidence
Exact sum: 17.8 + 15.9 + 10.3 + 12.5 = 56.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
05 · what price has already done

Market action

Tarsons Products Ltd has the strongest one-year price move in Medical Equipment at -2.6%. Hemant Surgical Industries Ltd leads on Mansfield relative strength against NIFTY at +47.3%. 3 of 6 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-09-11.

Price and relative strength

Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

06 · the story behind the numbers

Medical Equipment — the story behind the numbers

This is the written read behind the Medical Equipment figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 29 Jul 2026. 5 themes are live here.

The Medical Equipment sector analysis for the week ending 2026-07-19 covers 1 constituent, Hemant Surgical Industries Ltd (543916). The demand environment is classified as STRONG based on constituent reporting. Revenue growth was significant, with 543916 reporting a 195% YoY increase to ₹170 Crore. Profitability also expanded, with PAT rising 161% YoY to ₹12.8 Crore.

How old this read is: This read comes from our Medical Equipment sector brief dated 29 Jul 2026 — 50 days old. The numbers above it are newer than the words here.

What is live in this sector right now

Live themeSeverityEvidence on file
Profitability vulnerable to forex fluctuations and input cost increases associated with scaling production rapidly.Named for 543916mediumBetter product mix and increasing value addition expected to improve operating profit margin
Company exposed to forex risk as major portion of raw material requirements met through imports from Japan, China, South Korea without strong hedging mechanism.Named for 543916mediumIncreasing value addition and local manufacturing at Sambhaji Nagar facility to reduce import dependency
Exposed to regulatory changes in medical device pricing by NPPA and tightening environmental regulations on waste and pollution norms.Named for 543916mediumNo further detail is on file for this theme.
Product quality and safety related risks can lead to litigations or product liability claims in healthcare equipment supply.Named for 543916lowNo further detail is on file for this theme.
Fire occurred at company warehouse on September 25, 2024 causing damage to property, plant, equipment and inventory.Named for 543916lowManagement assessed impact and disclosed financial and operational implications

Sources: our Medical Equipment sector brief, 29 Jul 2026.

07 · compare level, then change

Revenue Scale & Growth Durability

Poly Medicure Ltd has the highest Revenue among the 6 Medical Equipment companies compared here, at ₹1,998 crore. Tarsons Products Ltd is next at ₹441 crore. The same company also holds the highest Revenue growth, at 18.4%. 5 of 6 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Poly Medicure Ltd is the scale leader at ₹1,998 crore, 352.7% ahead of Tarsons Products Ltd. Poly Medicure Ltd's growth is 18.4% from a ₹1,998 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

LeaderPoly Medicure Ltd · ₹1,998 crore
Gap352.7% versus #2 · Tarsons Products Ltd
Persistence8/8 recent comparable periods
Coverage5/6 companies · 73 observations

Investor read: Poly Medicure Ltd is the scale benchmark; Poly Medicure Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Poly Medicure Ltd's growth falls below Poly Medicure Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
1Poly Medicure Ltd POLYMED₹2.0K Cr
2Tarsons Products Ltd TARSONS⚠ unverified₹441 Cr
3Vasa Denticity Ltd DENTALKART⚠ unverified₹302 Cr
4Laxmi Dental Ltd LAXMIDENTL⚠ unverified₹287 Cr
5Prevest Denpro Ltd PREVEST · older report₹71 Cr
Revenue growthfastest growers
1Poly Medicure Ltd POLYMED18%
2Vasa Denticity Ltd DENTALKART⚠ unverified18%
3Prevest Denpro Ltd PREVEST · older report17%
4Laxmi Dental Ltd LAXMIDENTL⚠ unverified17%
5Tarsons Products Ltd TARSONS⚠ unverified11%
Revenue · company comparison
5/6 level · 5/6 change

On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyRevenueRevenue growthReported
Poly Medicure Ltd POLYMED₹525 Cr30%Jun 2026
Hemant Surgical Industries Ltd 543916₹167 Cr188%Mar 2026
Tarsons Products Ltd TARSONS⚠ unverified₹110 Cr21%Jun 2026
Vasa Denticity Ltd DENTALKART⚠ unverified₹83 Cr37%Jun 2026
Laxmi Dental Ltd LAXMIDENTL⚠ unverified₹75 Cr14%Jun 2026
Prevest Denpro Ltd PREVEST₹18 Cr23%Dec 2025
Full 20-quarter history · every available company

Revenue · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
—
—
—
—
—
—
—
—
—
—
₹58 Cr
—
₹65 Cr
—
₹167 Cr
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
₹48 Cr
₹55 Cr
₹60 Cr
₹57 Cr
₹62 Cr
₹61 Cr
₹66 Cr
₹72 Cr
₹66 Cr
₹74 Cr
₹75 Cr

Poly Medicure Ltd · POLYMED

₹223 Cr
₹230 Cr
₹257 Cr
₹249 Cr
₹275 Cr
₹285 Cr
₹307 Cr
₹321 Cr
₹337 Cr
₹340 Cr
₹378 Cr
₹385 Cr
₹420 Cr
₹424 Cr
₹441 Cr
₹403 Cr
₹444 Cr
₹494 Cr
₹535 Cr
₹525 Cr

Prevest Denpro Ltd · PREVEST

—
—
—
—
—
₹12 Cr
₹14 Cr
₹13 Cr
₹13 Cr
₹14 Cr
₹16 Cr
₹13 Cr
₹16 Cr
₹15 Cr
₹19 Cr
₹16 Cr
₹19 Cr
₹18 Cr
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

₹76 Cr
₹71 Cr
₹85 Cr
—
—
—
—
—
—
₹62 Cr
₹106 Cr
₹85 Cr
₹99 Cr
₹96 Cr
₹113 Cr
₹91 Cr
₹102 Cr
₹108 Cr
₹121 Cr
₹110 Cr

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
—
₹41 Cr
₹37 Cr
₹57 Cr
₹54 Cr
₹59 Cr
₹63 Cr
₹73 Cr
₹61 Cr
₹73 Cr
₹72 Cr
₹73 Cr
₹83 Cr

Revenue growth · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
188%
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
29%
11%
10%
26%
6.5%
21%
14%

Poly Medicure Ltd · POLYMED

—
—
—
17%
23%
24%
19%
29%
23%
19%
23%
20%
25%
25%
17%
4.7%
5.7%
17%
21%
30%

Prevest Denpro Ltd · PREVEST

—
—
—
—
—
—
—
—
—
11%
18%
-0.4%
23%
9.6%
14%
18%
15%
23%
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
55%
6.6%
7.7%
3.1%
13%
7.3%
21%

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
46%
71%
28%
13%
23%
15%
0.3%
37%
08 · compare level, then change

Operating Economics & Margin Trend

Prevest Denpro Ltd has the highest OPM among the 6 Medical Equipment companies compared here, at 33.9%. Poly Medicure Ltd is next at 24%. Vasa Denticity Ltd has the highest Margin change at +1.1 percentage points, so level and change sit with different companies. 6 of 6 companies report a comparable reading, the latest through Dec 2025.

What the numbers say: Prevest Denpro Ltd leads opm at 33.9%; Vasa Denticity Ltd leads margin change at +1.1 percentage points.

LeaderPrevest Denpro Ltd · 33.9%
Gap41.2% versus #2 · Poly Medicure Ltd
Persistence4/8 recent comparable periods
Coverage6/6 companies · 86 observations

Investor read: Prevest Denpro Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
1Prevest Denpro Ltd PREVEST · older report34%
2Poly Medicure Ltd POLYMED24%
3Tarsons Products Ltd TARSONS⚠ unverified24%
4Laxmi Dental Ltd LAXMIDENTL⚠ unverified19%
5Hemant Surgical Industries Ltd 5439169.0%
Margin changefastest expanders
1Vasa Denticity Ltd DENTALKART⚠ unverified+1.1 pp
2Laxmi Dental Ltd LAXMIDENTL⚠ unverified+1.0 pp
3Hemant Surgical Industries Ltd 5439160.0 pp
4Prevest Denpro Ltd PREVEST · older report−0.6 pp
5Poly Medicure Ltd POLYMED−2.0 pp
Operating margin · company comparison
6/6 level · 6/6 change
All-company data · latest reported quarter
CompanyOPMMargin changeReported
Prevest Denpro Ltd PREVEST34%−0.6 ppDec 2025
Poly Medicure Ltd POLYMED24%−2.0 ppJun 2026
Tarsons Products Ltd TARSONS⚠ unverified24%−3.5 ppJun 2026
Laxmi Dental Ltd LAXMIDENTL⚠ unverified19%+1.0 ppJun 2026
Hemant Surgical Industries Ltd 5439169.0%0.0 ppMar 2026
Vasa Denticity Ltd DENTALKART⚠ unverified6.1%+1.1 ppJun 2026
Full 20-quarter history · every available company

OPM · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
8.0%
—
11%
—
6.6%
—
13%
—
7.2%
—
9.0%
—
12%
—
9.0%
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
8.0%
21%
23%
15%
16%
16%
18%
15%
11%
18%
19%

Poly Medicure Ltd · POLYMED

23%
22%
22%
19%
24%
25%
27%
27%
25%
27%
26%
27%
27%
27%
27%
26%
26%
23%
21%
24%

Prevest Denpro Ltd · PREVEST

41%
43%
31%
37%
39%
41%
41%
37%
34%
33%
36%
34%
36%
34%
36%
35%
36%
34%
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

51%
47%
52%
—
—
—
—
—
—
37%
29%
22%
26%
31%
33%
27%
27%
29%
28%
24%

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
7.5%
—
9.2%
9.2%
8.8%
9.4%
14%
8.6%
11%
8.8%
8.8%
5.0%
8.0%
2.4%
0.4%
6.1%

Margin change · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
—
—
—
—
−1.5 pp
—
+1.7 pp
—
+0.7 pp
—
−3.7 pp
—
+4.8 pp
—
0.0 pp
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
+8.0 pp
−5.0 pp
−5.0 pp
0.0 pp
−5.0 pp
+2.0 pp
+1.0 pp

Poly Medicure Ltd · POLYMED

−5.5 pp
−6.2 pp
−3.8 pp
−7.4 pp
+0.8 pp
+2.8 pp
+5.4 pp
+8.3 pp
+1.5 pp
+2.0 pp
−1.0 pp
0.0 pp
+2.0 pp
0.0 pp
+1.0 pp
−1.0 pp
−1.0 pp
−4.0 pp
−6.0 pp
−2.0 pp

Prevest Denpro Ltd · PREVEST

—
—
—
—
−2.3 pp
−2.4 pp
+9.6 pp
+0.1 pp
−4.7 pp
−7.7 pp
−4.5 pp
−3.4 pp
+1.6 pp
+1.6 pp
−0.5 pp
+1.5 pp
+0.2 pp
−0.6 pp
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

—
−4.0 pp
+0.6 pp
—
—
—
—
—
—
—
—
—
—
−6.1 pp
+4.3 pp
+4.9 pp
+1.3 pp
−1.8 pp
−4.5 pp
−3.5 pp

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
—
+1.2 pp
—
+5.1 pp
−0.6 pp
+2.0 pp
−0.6 pp
−5.5 pp
−3.6 pp
−2.8 pp
−6.4 pp
−8.4 pp
+1.1 pp
09 · compare level, then change

Profit Scale & Acceleration

Poly Medicure Ltd has the highest Net profit among the 6 Medical Equipment companies compared here, at ₹313 crore. Laxmi Dental Ltd is next at ₹31 crore. Laxmi Dental Ltd has the highest Profit growth at 34.8%, so level and change sit with different companies. 5 of 6 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Poly Medicure Ltd leads with ₹313 crore of TTM profit, 10.1× the profit of Laxmi Dental Ltd. Laxmi Dental Ltd shows 34.8% growth from a ₹31 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

LeaderPoly Medicure Ltd · ₹313 crore
Gap10.1× versus #2 · Laxmi Dental Ltd
Persistence5/8 recent comparable periods
Coverage5/6 companies · 73 observations

Investor read: Poly Medicure Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
1Poly Medicure Ltd POLYMED₹313 Cr
2Laxmi Dental Ltd LAXMIDENTL⚠ unverified₹31 Cr
3Prevest Denpro Ltd PREVEST · older report₹21 Cr
4Vasa Denticity Ltd DENTALKART⚠ unverified₹11 Cr
5Tarsons Products Ltd TARSONS⚠ unverified₹11 Cr
Profit growthfastest growers
1Laxmi Dental Ltd LAXMIDENTL⚠ unverified35%
2Prevest Denpro Ltd PREVEST · older report17%
3Poly Medicure Ltd POLYMED-12%
4Vasa Denticity Ltd DENTALKART⚠ unverified-30%
5Tarsons Products Ltd TARSONS⚠ unverified-60%
Net profit · company comparison
5/6 level · 5/6 change
All-company data · latest reported quarter
CompanyNet profitProfit growthReported
Poly Medicure Ltd POLYMED₹85 Cr-8.6%Jun 2026
Hemant Surgical Industries Ltd 543916₹13 Cr160%Mar 2026
Laxmi Dental Ltd LAXMIDENTL⚠ unverified₹10 Cr25%Jun 2026
Prevest Denpro Ltd PREVEST₹5 Cr15%Dec 2025
Vasa Denticity Ltd DENTALKART⚠ unverified₹4 Cr52%Jun 2026
Tarsons Products Ltd TARSONS⚠ unverified₹-1 Cr-181%Jun 2026
Full 20-quarter history · every available company

Net profit · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
—
—
—
—
—
—
—
—
—
—
₹5 Cr
—
₹5 Cr
—
₹13 Cr
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
₹2 Cr
₹8 Cr
₹17 Cr
₹6 Cr
₹5 Cr
₹4 Cr
₹8 Cr
₹9 Cr
₹2 Cr
₹10 Cr
₹10 Cr

Poly Medicure Ltd · POLYMED

₹38 Cr
₹35 Cr
₹36 Cr
₹27 Cr
₹43 Cr
₹50 Cr
₹59 Cr
₹63 Cr
₹62 Cr
₹65 Cr
₹68 Cr
₹74 Cr
₹87 Cr
₹85 Cr
₹92 Cr
₹93 Cr
₹92 Cr
₹71 Cr
₹65 Cr
₹85 Cr

Prevest Denpro Ltd · PREVEST

—
—
—
—
—
₹4 Cr
₹5 Cr
₹4 Cr
₹4 Cr
₹4 Cr
₹5 Cr
₹4 Cr
₹5 Cr
₹4 Cr
₹5 Cr
₹5 Cr
₹6 Cr
₹5 Cr
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

₹25 Cr
₹21 Cr
₹29 Cr
—
—
—
—
—
—
₹10 Cr
₹10 Cr
₹4 Cr
₹10 Cr
₹5 Cr
₹10 Cr
₹2 Cr
₹3 Cr
₹5 Cr
₹4 Cr
₹-1 Cr

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
—
₹4 Cr
₹2 Cr
₹6 Cr
₹3 Cr
₹5 Cr
₹4 Cr
₹4 Cr
₹3 Cr
₹5 Cr
₹1 Cr
₹1 Cr
₹4 Cr

Profit growth · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
160%
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
150%
-50%
-53%
50%
-60%
150%
25%

Poly Medicure Ltd · POLYMED

—
—
—
-29%
13%
43%
64%
133%
44%
30%
15%
17%
40%
31%
35%
26%
5.8%
-16%
-29%
-8.6%

Prevest Denpro Ltd · PREVEST

—
—
—
—
—
—
—
—
—
1.4%
-8.8%
-11%
29%
23%
13%
27%
15%
15%
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
-47%
-1.2%
-56%
-68%
-4.2%
-59%
-181%

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
44%
63%
-35%
-21%
-14%
-66%
-70%
52%
10 · compare level, then change

Return On Capital Employed

Prevest Denpro Ltd has the highest ROCE among the 6 Medical Equipment companies compared here, at 25.2%. Hemant Surgical Industries Ltd is next at 19.6%. Laxmi Dental Ltd has the highest ROCE change at -1.4 percentage points, so level and change sit with different companies. 6 of 6 companies report a comparable reading, the latest through Dec 2025.

What the numbers say: Prevest Denpro Ltd leads ROCE at 25.2%, 5.6 percentage points above Hemant Surgical Industries Ltd. Laxmi Dental Ltd has the strongest latest improvement at -1.4 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

LeaderPrevest Denpro Ltd · 25.2%
Gap28.6% versus #2 · Hemant Surgical Industries Ltd
PersistenceNot enough history
Coverage6/6 companies · 46 observations

Investor read: Prevest Denpro Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
1Prevest Denpro Ltd PREVEST · older report25%
2Hemant Surgical Industries Ltd 54391620%
3Laxmi Dental Ltd LAXMIDENTL⚠ unverified15%
4Poly Medicure Ltd POLYMED13%
5Vasa Denticity Ltd DENTALKART⚠ unverified8.6%
ROCE changefastest improvers
1Laxmi Dental Ltd LAXMIDENTL⚠ unverified−1.4 pp
2Prevest Denpro Ltd PREVEST · older report−2.0 pp
3Tarsons Products Ltd TARSONS⚠ unverified−2.6 pp
4Poly Medicure Ltd POLYMED−3.4 pp
5Vasa Denticity Ltd DENTALKART⚠ unverified−10.8 pp
Return on capital · company comparison
6/6 level · 5/6 change
All-company data · latest reported quarter
CompanyROCEROCE changeReported
Laxmi Dental Ltd LAXMIDENTL⚠ unverified11%−1.4 ppJun 2026
Poly Medicure Ltd POLYMED9.8%−3.4 ppJun 2026
Vasa Denticity Ltd DENTALKART⚠ unverified5.0%−10.8 ppJun 2026
Tarsons Products Ltd TARSONS⚠ unverified2.3%−2.6 ppJun 2026
Full 20-quarter history · every available company

ROCE · reported quarter history

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
—
15%
—
27%
40%
12%
20%
11%
15%
11%
—

Poly Medicure Ltd · POLYMED

15%
—
14%
—
14%
—
17%
—
20%
26%
20%
27%
13%
22%
13%
23%
12%
17%
9.8%
—

Tarsons Products Ltd · TARSONS⚠ unverified

—
—
26%
—
21%
—
15%
—
12%
—
6.5%
—
4.8%
8.5%
4.9%
7.4%
3.8%
6.1%
2.3%
—

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
16%
—
15%
—
25%
48%
27%
37%
16%
22%
11%
14%
5.0%
—

ROCE change · reported quarter history

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
—
−3.2 pp
—
−16.2 pp
−25.0 pp
−1.4 pp
—

Poly Medicure Ltd · POLYMED

—
—
—
—
−1.4 pp
—
+2.7 pp
—
+5.8 pp
—
+3.1 pp
—
−6.9 pp
−4.7 pp
−6.5 pp
−4.0 pp
−0.9 pp
−4.8 pp
−3.4 pp
—

Tarsons Products Ltd · TARSONS⚠ unverified

—
—
—
—
—
—
−10.4 pp
—
−9.3 pp
—
−8.8 pp
—
−6.8 pp
—
−1.6 pp
—
−1.0 pp
−2.4 pp
−2.6 pp
—

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
—
—
—
+8.8 pp
—
+12.3 pp
—
−9.4 pp
−26.1 pp
−16.4 pp
−22.5 pp
−10.8 pp
—
11 · compare level, then change

Valuation Against Growth & Quality

Poly Medicure Ltd has the lowest PEG among the 6 Medical Equipment companies compared here, at 3.87×. Prevest Denpro Ltd has the lowest P/E at 24.8×, so level and change sit with different companies. 1 of 6 companies report a comparable reading, the latest through Jun 2026. Its PEG series carries 15 reported observations across the 20-quarter window.

What the numbers say: Poly Medicure Ltd has the lowest comparable PEG at 3.87×. Only 1 of 6 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

LeaderPoly Medicure Ltd · 3.87×
GapNot enough peers
Persistence0/8 recent comparable periods
Coverage1/6 companies · 15 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.
PEGlowest PEG
1Poly Medicure Ltd POLYMED3.9
P/Elowest P/E
1Prevest Denpro Ltd PREVEST · older report24.8
2Laxmi Dental Ltd LAXMIDENTL⚠ unverified32.1
3Hemant Surgical Industries Ltd 54391637.4
4Poly Medicure Ltd POLYMED55.1
5Vasa Denticity Ltd DENTALKART⚠ unverified58.3
Valuation · company comparison
1/6 level · 6/6 change
All-company data · latest reported quarter
CompanyPEGP/EReported
Poly Medicure Ltd POLYMED3.951.1Jun 2026
Hemant Surgical Industries Ltd 543916—27.5Mar 2026
Tarsons Products Ltd TARSONS⚠ unverified—91.5Jun 2026
Laxmi Dental Ltd LAXMIDENTL⚠ unverified—37.0Jun 2026
Vasa Denticity Ltd DENTALKART⚠ unverified—63.3Jun 2026
Prevest Denpro Ltd PREVEST—28.8Dec 2025
Full 20-quarter history · every available company

PEG · reported quarter history

Poly Medicure Ltd · POLYMED

1.6
2.1
3.7
—
—
1.4
—
2.8
1.1
2.0
1.0
1.6
3.2
3.5
3.1
2.5
—
2.7
3.9
—

P/E · reported quarter history

Hemant Surgical Industries Ltd · 543916

—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
42.9
—
27.5
—

Laxmi Dental Ltd · LAXMIDENTL⚠ unverified

—
—
—
—
—
—
—
—
—
—
—
—
—
—
1.6
54.6
60.1
57.5
33.1
37.0

Poly Medicure Ltd · POLYMED

60.0
60.0
54.5
48.8
61.1
61.0
58.3
61.5
61.3
61.2
61.3
71.7
81.0
83.6
70.4
63.5
55.5
49.2
35.4
51.1

Prevest Denpro Ltd · PREVEST

—
1.7
1.5
28.2
40.7
32.7
25.6
39.2
33.9
30.4
25.6
37.1
45.9
44.4
31.9
35.4
36.3
28.8
—
—

Tarsons Products Ltd · TARSONS⚠ unverified

—
0.2
0.2
36.1
43.1
36.7
28.1
31.9
27.8
27.9
20.8
26.4
54.7
65.3
53.7
68.8
59.4
59.8
44.3
91.5

Vasa Denticity Ltd · DENTALKART⚠ unverified

—
—
—
—
—
—
—
91.8
76.9
87.7
52.1
63.5
68.7
66.8
52.7
61.5
62.0
60.3
45.5
63.3
12 · before the conclusion, check the blind spots

What can make this comparison misleading?

This Medical Equipment comparison names 7 specific ways its own evidence can mislead, all listed below. 1 of the 6 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 3 draw at least one figure from a second feed with too little overlap to cross-check.

Keep these limits visible

  • A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
  • A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
  • The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
  • An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
  • 1 company has an older fundamental reporting date than the sector’s freshest reporters; its rank carries a stale marker.
  • 3 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
  • Thin comparisons: Valuation have fewer than three usable current readings.
13 · evidence and freshness

How was this comparison built?

This comparison is built from the reported filings of 6 Medical Equipment companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-09-11. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-09-11 · weekly price and relative-strength history
Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
Source standing1 cross-checked · 5 unverified · 0 withheld, of 6 graded companies.
How a second data feed is admitted, and what happens when it disagrees

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.

14 · questions investors ask, short speakable answers

Medical Equipment company comparison FAQs

These 24 answers restate the Medical Equipment comparison above in question form. Every one is computed from the same 6 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-09-11. Nothing here is estimated, and none of it is a recommendation.

Is the Medical Equipment sector outperforming NIFTY 500?

Medical Equipment has underperformed NIFTY 500 by 4.3% over 52 weeks and 18.6% over 13 weeks. 3 of 6 covered companies beat NIFTY on Mansfield relative strength, while 1 of 5 beat the sector itself.

Which Medical Equipment company is largest by revenue?

Poly Medicure Ltd leads with revenue of ₹1,998 crore, based on 5 of 6 comparable companies through Jun 2026.

Which Medical Equipment company is growing fastest?

Poly Medicure Ltd has the fastest current revenue growth at 18.4%, across 5 of 6 comparable companies.

Which Medical Equipment company has the strongest 4-Factor Sector Score?

Prevest Denpro Ltd ranks first at 64.2/100 with 56.9% evidence confidence. The score prioritizes research; it is not a buy recommendation.

Which Medical Equipment company has the lowest comparable PEG?

Poly Medicure Ltd has the lowest comparable PEG at 3.87, among 1 of 6 companies whose earnings and growth are steady enough for the ratio to mean anything.

How much history does this Medical Equipment comparison include?

The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

Is there a Nifty Medical Equipment index?

NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers Medical Equipment, this page builds its own equal-weight basket of 6 listed Medical Equipment companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.

Which are the best Medical Equipment stocks in India?

Ranked by this page's four-factor score, Prevest Denpro Ltd places first among 6 listed Medical Equipment companies, followed by Laxmi Dental Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

How many Medical Equipment stocks are listed in India?

This comparison covers 6 listed Medical Equipment companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

Which Medical Equipment company is the biggest?

Poly Medicure Ltd is the largest, with trailing-twelve-month revenue of ₹1,998 crore, ahead of Tarsons Products Ltd at ₹441 crore. That covers 5 of 6 companies with comparable reporting through Jun 2026.

Which Medical Equipment company has the best profit margins?

Prevest Denpro Ltd has the highest operating margin at 33.9%, from 6 of 6 comparable companies. Vasa Denticity Ltd shows the biggest recent improvement, at +1.1 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

Which Medical Equipment company makes the most profit?

Poly Medicure Ltd earns the most, at ₹313 crore of trailing-twelve-month net profit, from 5 of 6 comparable companies. Laxmi Dental Ltd has the fastest profit growth at 34.8%, though growth off a small or recovering profit base overstates how much has actually changed.

Which Medical Equipment company earns the highest return on capital?

Prevest Denpro Ltd leads on return on capital employed at 25.2%, across 6 of 6 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

Which Medical Equipment stock is the cheapest?

On PEG — where a LOWER number is cheaper — Poly Medicure Ltd screens cheapest at 3.87×. Only 1 of 6 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

Is the Medical Equipment sector beating the market?

Medical Equipment has underperformed NIFTY 500 by 4.3% over the last 52 weeks and 18.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 3 of 6 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

Which Medical Equipment stock has the strongest price momentum?

Hemant Surgical Industries Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

Which Medical Equipment company scores highest for research priority?

Prevest Denpro Ltd scores 64.2 out of 100 with 56.9% evidence confidence, from 18.9 points on growth and earnings, 18.9 on capital efficiency, 13.8 on valuation and 12.6 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

How many Medical Equipment companies does this comparison cover, and over what period?

It compares 6 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

What is the total market cap of the Medical Equipment sector?

The 6 Medical Equipment companies on this page carry ₹22,261 crore of combined market value. Poly Medicure Ltd is the largest at ₹17,622 crore, about 79% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-09-17.

What is the Medical Equipment sector's P/E ratio?

The median price-to-earnings ratio across the 6 Medical Equipment companies on this page is 55.1×, measured on the 6 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-09-17.

How is the Medical Equipment sector performing?

3 of the 6 covered Medical Equipment companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 4.3% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-09-17.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.

About

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI